Keith Speights
TMFFishBiz
Keith Speights is a contributing Motley Fool healthcare analyst covering publicly traded companies across pharmaceuticals, biotechnology, medical devices, technology, and marijuana. Prior to The Motley Fool, Keith was CEO of Constant Care Technology, a healthcare technology company; vice president of American HealthTech, a healthcare software company; and a director of operations for Blue Cross Blue Shield of Mississippi, a health insurer. He holds a B.S. in Industrial Engineering from Mississippi State University.
Recent Articles by Keith Speights

Jul 11, 2025
by Keith Speights
3 No-Brainer Warren Buffett Stocks to Buy Right Now

Jul 10, 2025
by Keith Speights
The Best Vanguard ETF to Invest $500 In Right Now

Jul 5, 2025
by Keith Speights
The Best Stocks to Invest $1,000 In Right Now

Jul 3, 2025
by Keith Speights
What Is a PDUFA Date?

Jun 30, 2025
by Keith Speights
3 Stocks I Plan to Hold for the Next 20 Years
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.